Endocrine profile in a patient with familial breast cancer. A case-control study

Henry T. Lynch, R. E. Harris, J. Fishman, J. F. Lynch, K. Marrero, K. Maloney

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Urinary and blood hormonal profiles were studied throughout a monthly cycle in a patient with familial breast cancer. Two comparison cohorts (one high-risk and one low-risk) were studied concurrently. Findings disclosed that our breast cancer-affected patient showed a distinctive hormonal pattern characterized by significant elevation throughout the cycle of plasma estrone, estradiol, and prolactin. Save for a depression in plasma FSH in the early follicular phase, this hormone, as well as LH and progesterone patterns in our patient, were similar to the comparison cohorts. Urinary estrone and estradiol patterns in our patient were elevated early in the follicular phase. Our patient also showed a depression in urinary estrone, estradiol, and estriol following ovulation, which persisted throughout the luteal phase. Blood and urinary hormone patterns in the high-risk cohort were not demonstrably different from the low-risk cohort, with the exception of plasma prolactin. The results on the latter hormone showed an unexpected significant depression throughout most of the menstrual cycle in this low-risk cohort. We conclude that estrone and estradiol elevations, as clearly evidenced in out breast cancer-affected patient, may provide clues that ultimately might be used as an etiologic discriminant for breast cancer risk and which may also play a pathogenic role in this disease. Since this involved a single patient, our conclusions must be interpreted cautiously.

Original languageEnglish
Pages (from-to)1860-1869
Number of pages10
JournalCancer
Volume44
Issue number5
StatePublished - 1979

Fingerprint

Case-Control Studies
Estrone
Estradiol
Follicular Phase
Hormones
Breast Neoplasms
Prolactin
Estriol
Luteal Phase
Menstrual Cycle
Ovulation
Familial Breast Cancer
Progesterone

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Lynch, H. T., Harris, R. E., Fishman, J., Lynch, J. F., Marrero, K., & Maloney, K. (1979). Endocrine profile in a patient with familial breast cancer. A case-control study. Cancer, 44(5), 1860-1869.

Endocrine profile in a patient with familial breast cancer. A case-control study. / Lynch, Henry T.; Harris, R. E.; Fishman, J.; Lynch, J. F.; Marrero, K.; Maloney, K.

In: Cancer, Vol. 44, No. 5, 1979, p. 1860-1869.

Research output: Contribution to journalArticle

Lynch, HT, Harris, RE, Fishman, J, Lynch, JF, Marrero, K & Maloney, K 1979, 'Endocrine profile in a patient with familial breast cancer. A case-control study', Cancer, vol. 44, no. 5, pp. 1860-1869.
Lynch HT, Harris RE, Fishman J, Lynch JF, Marrero K, Maloney K. Endocrine profile in a patient with familial breast cancer. A case-control study. Cancer. 1979;44(5):1860-1869.
Lynch, Henry T. ; Harris, R. E. ; Fishman, J. ; Lynch, J. F. ; Marrero, K. ; Maloney, K. / Endocrine profile in a patient with familial breast cancer. A case-control study. In: Cancer. 1979 ; Vol. 44, No. 5. pp. 1860-1869.
@article{58fbb14855b44632ad497307031c0f53,
title = "Endocrine profile in a patient with familial breast cancer. A case-control study",
abstract = "Urinary and blood hormonal profiles were studied throughout a monthly cycle in a patient with familial breast cancer. Two comparison cohorts (one high-risk and one low-risk) were studied concurrently. Findings disclosed that our breast cancer-affected patient showed a distinctive hormonal pattern characterized by significant elevation throughout the cycle of plasma estrone, estradiol, and prolactin. Save for a depression in plasma FSH in the early follicular phase, this hormone, as well as LH and progesterone patterns in our patient, were similar to the comparison cohorts. Urinary estrone and estradiol patterns in our patient were elevated early in the follicular phase. Our patient also showed a depression in urinary estrone, estradiol, and estriol following ovulation, which persisted throughout the luteal phase. Blood and urinary hormone patterns in the high-risk cohort were not demonstrably different from the low-risk cohort, with the exception of plasma prolactin. The results on the latter hormone showed an unexpected significant depression throughout most of the menstrual cycle in this low-risk cohort. We conclude that estrone and estradiol elevations, as clearly evidenced in out breast cancer-affected patient, may provide clues that ultimately might be used as an etiologic discriminant for breast cancer risk and which may also play a pathogenic role in this disease. Since this involved a single patient, our conclusions must be interpreted cautiously.",
author = "Lynch, {Henry T.} and Harris, {R. E.} and J. Fishman and Lynch, {J. F.} and K. Marrero and K. Maloney",
year = "1979",
language = "English",
volume = "44",
pages = "1860--1869",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Endocrine profile in a patient with familial breast cancer. A case-control study

AU - Lynch, Henry T.

AU - Harris, R. E.

AU - Fishman, J.

AU - Lynch, J. F.

AU - Marrero, K.

AU - Maloney, K.

PY - 1979

Y1 - 1979

N2 - Urinary and blood hormonal profiles were studied throughout a monthly cycle in a patient with familial breast cancer. Two comparison cohorts (one high-risk and one low-risk) were studied concurrently. Findings disclosed that our breast cancer-affected patient showed a distinctive hormonal pattern characterized by significant elevation throughout the cycle of plasma estrone, estradiol, and prolactin. Save for a depression in plasma FSH in the early follicular phase, this hormone, as well as LH and progesterone patterns in our patient, were similar to the comparison cohorts. Urinary estrone and estradiol patterns in our patient were elevated early in the follicular phase. Our patient also showed a depression in urinary estrone, estradiol, and estriol following ovulation, which persisted throughout the luteal phase. Blood and urinary hormone patterns in the high-risk cohort were not demonstrably different from the low-risk cohort, with the exception of plasma prolactin. The results on the latter hormone showed an unexpected significant depression throughout most of the menstrual cycle in this low-risk cohort. We conclude that estrone and estradiol elevations, as clearly evidenced in out breast cancer-affected patient, may provide clues that ultimately might be used as an etiologic discriminant for breast cancer risk and which may also play a pathogenic role in this disease. Since this involved a single patient, our conclusions must be interpreted cautiously.

AB - Urinary and blood hormonal profiles were studied throughout a monthly cycle in a patient with familial breast cancer. Two comparison cohorts (one high-risk and one low-risk) were studied concurrently. Findings disclosed that our breast cancer-affected patient showed a distinctive hormonal pattern characterized by significant elevation throughout the cycle of plasma estrone, estradiol, and prolactin. Save for a depression in plasma FSH in the early follicular phase, this hormone, as well as LH and progesterone patterns in our patient, were similar to the comparison cohorts. Urinary estrone and estradiol patterns in our patient were elevated early in the follicular phase. Our patient also showed a depression in urinary estrone, estradiol, and estriol following ovulation, which persisted throughout the luteal phase. Blood and urinary hormone patterns in the high-risk cohort were not demonstrably different from the low-risk cohort, with the exception of plasma prolactin. The results on the latter hormone showed an unexpected significant depression throughout most of the menstrual cycle in this low-risk cohort. We conclude that estrone and estradiol elevations, as clearly evidenced in out breast cancer-affected patient, may provide clues that ultimately might be used as an etiologic discriminant for breast cancer risk and which may also play a pathogenic role in this disease. Since this involved a single patient, our conclusions must be interpreted cautiously.

UR - http://www.scopus.com/inward/record.url?scp=0018629322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018629322&partnerID=8YFLogxK

M3 - Article

VL - 44

SP - 1860

EP - 1869

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 5

ER -